Hinge Health, Inc. (HNGE)
97.67
-0.27
(-0.28%)
USD |
NYSE |
Oct 02, 16:00
97.63
-0.04
(-0.04%)
Pre-Market: 20:00
Hinge Health Shareholders Equity (Quarterly) : 344.33M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 344.33M |
| March 31, 2026 | 311.56M |
| December 31, 2025 | 378.54M |
| September 30, 2025 | 407.87M |
| June 30, 2025 | 373.65M |
| March 31, 2025 | 438.82M |
| Date | Value |
|---|---|
| December 31, 2024 | 416.70M |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 427.28M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | 2.990B |
| Interpace Biosciences, Inc. | 23.24M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Medical Marijuana, Inc. | 50.08M |
| Acro Biomedical Co. Ltd. | -0.4448M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 827.40M |
| Total Liabilities (Quarterly) | 483.07M |
| Debt to Equity Ratio | 0.0171 |
| Current Ratio | 1.246 |
| Net Debt Paydown Yield | 0.01% |